NCT07472621 2026-03-16
Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
Henan Cancer Hospital
Not yet recruiting
Henan Cancer Hospital
GenomeFrontier Therapeutics TW Co., Ltd.
The Lymphoma Academic Research Organisation
Ain Shams University
Pell Bio-Med Technology Co., Ltd.